Evaluation of the thyroid nodule

Department of Internal Medicine, The Reading Hospital and Medical Center, West Reading, Philadelphia, USA.
Postgraduate medical journal (Impact Factor: 1.54). 05/2009; 85(1002):190-5. DOI: 10.1136/pgmj.2008.072140
Source: PubMed

ABSTRACT The annual incidence of thyroid cancer worldwide is 1 case per 100 000 men and 2.6 cases per 100 000 women. Most thyroid nodules are asymptomatic and are discovered incidentally on physical examination, self-palpation or incidentally on imaging studies performed for unrelated reasons. Although the majority of both palpable and non-palpable thyroid nodules are benign, approximately 5% may represent thyroid cancer. Thyroid-stimulating hormone, thyroid ultrasound and fine-needle aspiration biopsy are key tests to guide management. Physicians caring for patients with thyroid nodules need to develop a rational, cost-effective approach to ordering and interpreting imaging and diagnostic tests in the evaluation of the thyroid nodule.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The detection of molecular alterations in the signaling pathways in thyroid carcinogenesis relates to some diagnostic, prognostic and treatment issues. The addition of the molecular profile to a well-differentiated thyroid cancer approach improves the accuracy of cancer detection, the prognostication and the selection of therapeutic targets for a more personalized management. It is expected that in the next few years, guidelines for thyroid cancer treatment will require a molecular marker panel to define the best treatment for this disease. BRAF and RAS mutations and RET/papillary thyroid cancer (PTC) and PAX8/PPARγ rearrangements, associated with the abnormal regulation of microRNA, constitute the most frequent molecular alterations identified in PTC. The clinical implications of the expression of these altered genes and molecules and the usefulness of these data for tailoring the approach to the disease and patient are the focus of this review.
    03/2013; 2(1):35-43. DOI:10.1007/s40136-013-0031-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess the clinical value of quantitative elastosonography compared with multiparametric ultrasound in differentiating the nature of thyroid nodules. Ninety-seven consecutive patients (32 males, 65 females, mean age, 54 years, range 20-81 years) with thyroid nodules previously detected at color-Doppler ultrasound (CDUS), were prospectively examined with elastosonography with dedicated quantitative software (Elasto-Q, Toshiba) before surgery. Ultrasound examination and elastosonography were evaluated by two investigators in consensus. US features, color-Doppler pattern, and strain ratio value were evaluated. Sensitivity and specificity of CDUS and sono-elastography were compared using X(2) test and ROC curves. Sensitivity and specificity of hypoechogenicity, irregular margins or suspicious halo features, CDUS blood flow pattern, and strain ratio in the diagnosis of malignant nodules were 56.8%, 62.2%, 54.1% and 97.3% and 71.7%, 93.3%, 28.3%, and 91.7%, respectively. Elastosonography was more sensitive and specific than all ultrasonographic features in predicting malignancy of the thyroid nodules (p<0.0001). According to elastosonographic features the lesions characterized by strain ratio ≥ 2 were highly likely to be of malignant nature (p<0.0001, O.R. 396, 95%, CI: 44-3530). The results of the present study suggest that elastosonography with Q system is a valuable tool in the characterization of thyroid nodules and it seems to be far more accurate than CDUS. These findings as well as those of previous studies support its use in selecting patients who are candidates for surgery.
    European journal of radiology 02/2012; 81(10):2678-83. DOI:10.1016/j.ejrad.2011.11.056 · 2.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was done to compare quantitative elastosonography and ultrasound analysis in the characterisation of thyroid nodules. From July 2009 to September 2011, 123 patients with 147 thyroid nodules were included in our study. All patients enrolled had to undergo thyroidectomy because of nodular thyroid disease (goitre or nodules). After preliminary examination with conventional ultrasound (US) and colour Doppler US, the patients were examined with elastosonography, using high-level equipment (Toshiba Aplio XG) and quantitative software (Elasto-Q). Each lesion was characterised using an US score (echogenicity, borders, microcalcifications and colour Doppler pattern), and then by elastosonographic strain ratio. Each patient subsequently underwent thyroidectomy. Histological results were used as the gold standard. Histological examination demonstrated 89 benign and 58 malignant lesions. On average, the strain ratio value was 2.84±2.69 (range, 0.05-14.5; p=0.001). Sensitivity and specificity of the US score were about 56% and 72%, respectively, whereas those of the strain ratio were 93% and 89%, using a cut-off of 2 obtained with receiver operating characteristic (ROC) curve analysis. Elastosonography was more accurate than US and colour Doppler US in characterising thyroid nodules (p=0.002). Quantitative elastosonography is a useful diagnostic tool in the evaluation of thyroid lesions, and can be used to limit fine-needle aspiration cytology and improve the selection of patients for thyroidectomy.
    La radiologia medica 06/2013; 118(6). DOI:10.1007/s11547-013-0950-y · 1.37 Impact Factor


Available from
Dec 20, 2014